Skip to main content
Back
Watch Compare

Celularity Inc

Data quality: 100%
Also listed as CELUW NASDAQ
CELU
NASDAQ Manufacturing Chemicals
$1.27
▼ $0.09 (-6.62%)
Mkt Cap: 38.93 M
Price
$1.35
Mkt Cap
38.93 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -6.68 M
Capital efficient — spends only 0.31% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)138.11%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-76.69%
Net Margin-198.75%
Op. Margin-119.60%

Safety

Debt / Equity
N/A
Current Ratio0.16
Interest CoverageN/A

Valuation

PE (TTM)
-0.48
Above sector avg (-1.49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -0.5 -1.5
P/B — 1.6
ROE % — -54.5
Net Margin % -198.8 -41.5
Rev Growth 5Y % — 1.9
D/E — 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

Earnings Surprises

Last 2 quarters
Quarter Est. EPS Actual EPS Surprise
Q22023 -$0.30 -$2.70 -800.0%
Q12023 -$2.40 -$4.10 -70.8%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 138.11% Revenue Growth (3Y) 73.68%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 40.58 M Net Income (TTM) -80.65 M
ROE N/A ROA -68.78%
Gross Margin N/A Operating Margin -119.60%
Net Margin -198.75% Free Cash Flow (TTM) -6.68 M
ROIC -76.69% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.16
Interest Coverage N/A Asset Turnover 0.35
Working Capital -54.72 M Tangible Book Value -35.57 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.48 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.96
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -17.17%
Market Cap 38.93 M Enterprise Value 38.81 M
Per Share
EPS (Diluted TTM) -3.33 Revenue / Share 1.41
FCF / Share -0.23 OCF / Share -0.23
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.31% FCF Conversion 8.29%
SBC-Adj. FCF -7.47 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 54.22 M 22.77 M 17.98 M 21.34 M —
Net Income -57.89 M -196.30 M 14.19 M -100.12 M -2.63 M
EPS (Diluted) -2.64 -11.02 0.09 — —
Gross Profit — 6.76 M -1.69 M 11.68 M —
Operating Income -38.36 M -192.29 M -25.60 M -109.06 M -4.22 M
EBITDA — — — — —
R&D Expenses 17.39 M 30.47 M 78.36 M 88.35 M —
SG&A Expenses 58.64 M 50.58 M 66.02 M 71.34 M —
D&A 7.92 M 9.32 M 9.44 M 8.82 M —
Interest Expense — — — — —
Income Tax 10,000.0 10,000.0 13,000.0 20,000.0 191,644.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 132.68 M 143.89 M 401.07 M 414.13 M 292.16 M
Total Liabilities 123.85 M 102.93 M 202.17 M 314.71 M 14.22 M
Shareholders' Equity 8.84 M 40.96 M 198.90 M 99.42 M 5.00 M
Total Debt — 17.22 M 37.60 M — —
Cash & Equivalents 738,000.0 227,000.0 13.97 M 37.24 M 314,696.0
Current Assets 20.56 M 19.79 M 33.50 M 59.10 M 359,289.0
Current Liabilities 53.68 M 67.30 M 62.09 M 26.23 M 3.41 M

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Value Price/Sales Ratio Focus (Ken Fisher)
#71 of 245
69

Recent Activity

Entered Price/Sales Ratio Focus (Ken Fisher)
Apr 12, 2026